attention us:
Product Catalogue
Contact information
Welcome to call the service hotline



Nervous system

Location>Home>Nervous system>N010:SMA panel

    Spinal muscular atrophy (SpinalMuscularAtrophy) is one of the most common fatal neuromuscular disease, caused by motor neuron degeneration of spinal cord anterior horn cells result in the proximal muscle symmetry, atrophy and weakness of patient, eventually respiratory failure and even death. The probability incidence rate of disease is 1 / 6,000 to 1 / 10,000. And if the couple had a child with SMA birth, children with the regeneration is probability 25%, raw asymptomatic carriers is 50%, and give birth to a normal child is 25%. Genetic testing of amyotrophic lateral sclerosis is to use the target area capture technology and high-throughput sequencing technology, to detect and analysis the related genes of client's Spinal muscular atrophy. And in the meantime, it can be in early screening of patients with Spinal muscular atrophy, as well as to realize individualized medication and specificity of gene therapy to provide important basis for patients through combining with the history, clinical manifestation and information. Mygenostics is aimed to detect and analysis multiple subtypes of Spinal muscular atrophy by hand in hand with clinical experts, combined with a new generation of high-throughput sequencing technology and bioinformatics analysis, to provide reliable basis for early diagnosis of Spinal muscular atrophy patients.

     Spinal muscular atrophy (SMA), SMN1 and SMN2 gene del/dup, MLPA analysis